Pantoprazole treatment does not invoke anti-inflammatory properties in vivo

International Immunopharmacology

Volumn 4, Issue 8, 2004, Pages 1051-1057

  Becker, Tagliane Liza ^a   Maróstica, Marta ^a   Ribeiro, Marcelo Lima ^a   De Mendonça, Sérgio ^a   Gambero, Alessandra ^a   Pedrazzoli Jr , José ^a  

^a S Francisco Univ Medical School   (Brazil)

Author keywords

Air pouch; Carrageenan; Dexamethasone; Helicobacter pylori; Neutrophil; Proton pump inhibitors

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; CIMETIDINE; DEXAMETHASONE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; EXUDATE; HELICOBACTER PYLORI; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; SUSPENSION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CARRAGEENAN; H(+)-K(+)-EXCHANGING ATPASE; HELICOBACTER PYLORI; INFLAMMATION; MALE; NEUTROPHILS; OMEPRAZOLE; RATS; RATS, WISTAR; SULFOXIDES;

EID: 3042654729     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.04.009     Document Type: Article

References (20)

1. Caro J.J., Salas M., Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clin. Ther. 23:2001;998-1017
2. Konturek S.J., Brzozowski T., Radecki T. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion. 27:1983;159-164
3. Blandizzi C., Natale G., Gherardi G., Lazzeri G., Marveggio C., et al. Gastroprotective effects of pantoprazole against experimental mucosal damage. Fundam. Clin. Pharmacol. 14:2000;89-99
4. Wandall J.H. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut. 33:1992;617-621
5. Suzuki M., Mori M., Miura S., Suematsu M., Fukumura D., et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic. Biol. Med. 21:1996;727-731
6. Agastya G., West B.C., Callahan J.M. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol. Immunotoxicol. 22:2000;357-372
7. Yoshida N., Yoshikawa T., Tanaka Y., Fujita N., Kassai K., et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther. 14:2000;74-81
8. Crabtree J.E. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment. Pharmacol. Ther. 10:1996;29-37
9. Wallace J.L., Keenan C.M., Granger D.N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 259:1990;G462-G467
10. Mikawa K., Akamatsu H., Nishina K., Niwa Y. Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions. Can. J. Anaesth. 48:2001;421-422
11. Gambero A., Becker T.L., Gurgueira S.A., Benvengo Y.H., Ribeiro M.L., et al. Acute inflammatory response induced by Helicobacter pylori in the rat air pouch. FEMS Immunol. Med. Microbiol. 38:2003;193-198
12. Shay H., Komarov A.S., Fels S.S., Meranze D., Gruenstein M., Siplet H. A simple method for the uniform production of gastric ulceration in rats. Gastroenterology. 5:1945;43-61
13. Edwards J.C., Sedgwick A.D., Willoughby D.A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134:1981;147-156
14. Shimaoka M., Takagi J., Springer T.A. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:2002;485-516
15. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101
16. Suzuki M., Mori M., Fukumura D., Suzuki H., Miura S., Ishii H. Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori. J. Gastroenterol. Hepatol. 14:1999;27-31
17. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:1995;301-308
18. Perretti M. Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends Pharmacol. Sci. 18:1997;418-425
19. Odou P., Martin P., Membre S., Gressier B., Tamiji L., et al. Omeprazole-induced leukopenia. A case report. J. Clin. Pharm. Ther. 24:1999;317-321
20. Ohara T., Arakawa T. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig. Dis. Sci. 44:1999;1710-1715